BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1457582)

  • 1. Treatment of neutropenia in Felty's syndrome with granulocyte-macrophage colony-stimulating factor--hematological response accompanied by pulmonary complications with lethal outcome.
    Gari-Bai AR; Rochlitz C; Riewald M; Oertel J; Huhn D
    Ann Hematol; 1992 Nov; 65(5):232-5. PubMed ID: 1457582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of pneumonia and arthritis in Felty's syndrome by treatment with granulocyte-macrophage colony-stimulating factor (GM-CSF).
    Lübbe AS; Schwella N; Riess H; Huhn D
    Blut; 1990 Dec; 61(6):379-80. PubMed ID: 2291988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of colony-stimulating factors in the treatment of neutropenia associated with collagen vascular disease.
    Starkebaum G
    Curr Opin Hematol; 1997 May; 4(3):196-9. PubMed ID: 9209836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte-macrophage colony-stimulating factor treatment of neutropenia associated with Felty's syndrome.
    Markusse HM; Breedveld FC; Fibbe WE
    Arthritis Rheum; 1990 Dec; 33(12):1865-7. PubMed ID: 2261008
    [No Abstract]   [Full Text] [Related]  

  • 5. Felty's syndrome: favorable response to granulocyte-macrophage colony-stimulating factor in the acute phase.
    Kaiser U; Klausmann M; Kolb G; Pflüger KH; Havemann K
    Acta Haematol; 1992; 87(4):190-4. PubMed ID: 1519433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor.
    Hellmich B; Schnabel A; Gross WL
    Semin Arthritis Rheum; 1999 Oct; 29(2):82-99. PubMed ID: 10553980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term remission of neutropenia in Felty's syndrome after a short GM-CSF treatment.
    Pereira J; Velloso ED; Loterio HA; Laurindo IM; Chamone DA
    Acta Haematol; 1994; 92(3):154-6. PubMed ID: 7871957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GM-CSF and G-CSF in Felty's syndrome.
    Wagner DR; Combe C; Gresser U
    Clin Investig; 1993 Feb; 71(2):168-71. PubMed ID: 7681711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term correction of neutropenia in Felty's syndrome with granulocyte colony-stimulating factor.
    Wandt H; Seifert M; Falge C; Gallmeier WM
    Ann Hematol; 1993 May; 66(5):265-6. PubMed ID: 7685194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained response in Felty's syndrome to prolonged administration of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF).
    Moore DF; Vadhan-Raj S
    Am J Med; 1995 Jun; 98(6):591-4. PubMed ID: 7778576
    [No Abstract]   [Full Text] [Related]  

  • 11. Felty's syndrome treated with rhG-CSF associated with flare of arthritis and skin rash.
    McMullin MF; Finch MB
    Clin Rheumatol; 1995 Mar; 14(2):204-8. PubMed ID: 7540527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [G-CSF versus GM-CSF in the treatment of neutropenia in a patient with Felty's syndrome on hemodialysis].
    del Pozo C; Ortiz de Salazar MI; Torregrosa I; Sánchez L; Albero MD; Bauza J
    Nefrologia; 2000; 20(5):455-8. PubMed ID: 11100668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential administration of cyclophosphamide and granulocyte-colony stimulating factor relieves impaired myeloid maturation in Felty's syndrome.
    Pixley JS; Yoneda KY; Manalo PB
    Am J Hematol; 1993 Aug; 43(4):304-6. PubMed ID: 7690520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GM-CSF versus G-CSF in the treatment of infectious complication in Felty's syndrome--a case report.
    Kaiser U; Klausmann M; Richter G; Pflüger KH
    Ann Hematol; 1992 Apr; 64(4):205-6. PubMed ID: 1374651
    [No Abstract]   [Full Text] [Related]  

  • 15. GM-CSF in the treatment of Felty syndrome.
    Joseph G; Neustadt DH; Hamm J; Kellihan M; Hadley T
    Am J Hematol; 1991 May; 37(1):55-6. PubMed ID: 2024642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flare of arthritis with successful treatment of Felty's syndrome with granulocyte colony stimulating factor (GCSF).
    Hayat SQ; Hearth-Holmes M; Wolf RE
    Clin Rheumatol; 1995 Mar; 14(2):211-2. PubMed ID: 7540528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary aspergillosis of the larynx in a patient with Felty's syndrome.
    Morelli S; Sgreccia A; Bernardo ML; Della Rocca C; Gallo A; Valesini G
    Clin Exp Rheumatol; 2000; 18(4):523-4. PubMed ID: 10949734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prolonged use of granulocyte colony stimulating factor in Felty's syndrome.
    Graham KE; Coodley GO
    J Rheumatol; 1995 Jan; 22(1):174-6. PubMed ID: 7699667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological agents in the management of Felty's syndrome: a systematic review.
    Narváez J; Domingo-Domenech E; Gómez-Vaquero C; López-Vives L; Estrada P; Aparicio M; Martín-Esteve I; Nolla JM
    Semin Arthritis Rheum; 2012 Apr; 41(5):658-68. PubMed ID: 22119104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Fcgamma receptor III and high granulocyte colony-stimulating factor serum levels correlate with the risk of infection in neutropenia due to Felty's syndrome or systemic lupus erythematosus.
    Hellmich B; Csernok E; de Haas M; von dem Borne AE; Schatz H; Gross WL; Schnabel A
    Am J Med; 2002 Aug; 113(2):134-9. PubMed ID: 12133752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.